Navigation Links
PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
Date:8/20/2007

Novel cardioprotective agent to move forward in Phase III development

NEW YORK, Aug. 20 /PRNewswire/ -- PeriCor Therapeutics announced today that its licensing agreement for acadesine with Schering-Plough Corporation has become effective. The agreement grants Schering-Plough exclusive worldwide rights for the development and commercialization of PeriCor's lead compound, acadesine. Financial terms of the transaction were not disclosed.

Acadesine is currently under evaluation in Phase III clinical development as an intravenous infusion for the prevention of adverse cardiovascular and cerebrovascular outcomes that occur as complications associated with ischemia-reperfusion injury in patients undergoing coronary artery bypass graft (CABG) surgery. Acadesine has been studied in placebo-controlled trials that enrolled more than 4,000 patients. Schering-Plough will conduct an additional randomized, placebo-controlled Phase III trial needed for regulatory approval. An agent, such as acadesine, that can be shown to reduce the surgical complications of stroke, heart failure and death that can accompany CABG would not only make an important contribution to patients' well-being, but would also be anticipated to reduce health care costs dramatically.

"Schering-Plough possesses the vital organizational and financial resources to complete the clinical and regulatory processes required to make this life-saving medicine available to cardiac surgeons and anesthesiologists around the world," said Richard R. Stover, President and Chief Executive Officer of PeriCor Therapeutics. Commenting further, Mr. Stover said, "We are especially impressed with the caliber of Schering-Plough's cardiovascular group in clinical development, medical, and marketing activities and their unparalleled record of innovation in this therapeutic area."

Previous clinical experience with acadesine in placebo-controlled studies in CABG surgery suggests that acadesine may have unique
'/>"/>

SOURCE PeriCor Therapeutics, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3

Related biology technology :

1. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
2. Speaker announces business members of IT Task Force
3. Doyle announces technology tax credits for Berbee
4. Doyle announces new energy, global warming policies
5. Doyle announces $80M renewable energy strategy
6. GE announces first installation of Discovery VCT
7. UWM announces winners of RGI awards
8. Third Wave announces two senior management appointments
9. Mirus announces new method for making antibodies
10. Merge announces sofware updates, upcoming acquisition
11. Small Tree announces ethernet solution for Apple Xserv G5
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... According to Jeff Howell, Partner of ... Global, new development in Downtown Toronto is expanding at ... another 755 storeys of new development last week (including ... be dominating the Toronto skyline for the foreseeable future ... thirst for new development. , As the Toronto city ...
(Date:9/15/2014)... , Sept. 15, 2014 ... on revolutionizing the treatment of cancer through the ... cells, announced that, together with the Asbestos Disease ... Cancer Institute New South Wales (NSW) Premier,s Award ... four recipients are the hospitals that will be ...
(Date:9/15/2014)... led by Northeastern University has developed a novel ... a variety of nanocarbon structures in carbon nanotube ... which will allow the researchers to tailor the ... applications ranging from electronic devices to CNT-reinforced composite ... equipment. , Their findings were published in the ...
(Date:9/15/2014)... AUSTIN, Texas , Sept. 15, 2014 The ... changes in climate, says a new article published by the ... Ahmed , PhD, on climate change and its effects on ... part of an extensive study conducted by Dr. Ahmed in ... China and has implications for the future ...
Breaking Biology Technology:ITRA Global Reports Downtown Toronto Real Estate Development is in High Gear 2ITRA Global Reports Downtown Toronto Real Estate Development is in High Gear 3EnGeneIC Named a Recipient of the Cancer Institute NSW Premier's Award for Excellence in Translational Cancer Research 2EnGeneIC Named a Recipient of the Cancer Institute NSW Premier's Award for Excellence in Translational Cancer Research 3Northeastern University Researchers Develop Novel Method for Working with Nanotubes 2Tea Taste and Quality Affected by Climate Change 2Tea Taste and Quality Affected by Climate Change 3Tea Taste and Quality Affected by Climate Change 4
... -- Aurora Health Care is planning to open a ... new digital hospital will include the latest in digital ... physicians will benefit from enterprise storage and distribution of ... , ,Aurora Health Care established in 1984 is ...
... Growth Council seems like a well-intentioned group, but Im concerned ... of council members, I was astonished that only three women ... , ,So I set-off on a fact-finding mission and found ... the U.S. are started by women, Gen Xers (b. 1961-1981), ...
... Wis.In a business world where even very specialized services and ... staying one step ahead of the rat race. , ,The ... processing chips for high-end networking and computing customers such as ... name a few. , ,WTN sat down with Jeff ...
Cached Biology Technology:Aurora Selects New Imaging Technology 2Silicon Logic Engineering Ramps Up Custom Chips 2Silicon Logic Engineering Ramps Up Custom Chips 3Silicon Logic Engineering Ramps Up Custom Chips 4
(Date:9/16/2014)... than $100 trillion in cumulative public and private ... (CO2)a 40 percent reduction of urban passenger transport ... expands public transportation, walking and cycling in cities, ... University of California, Davis, and the Institute for ... an estimated 1.4 million early deaths could be ...
(Date:9/16/2014)... has its own bacterial identity. That,s the conclusion of ... who studied the genetic fingerprints of bacteria on 57 ... "This study demonstrates for the first time that host ... strategies possess very different microbial communities on their leaves," ... researcher in the UO,s Institute of Ecology and Evolution ...
(Date:9/16/2014)... XL pipeline (KXL) would likely increase oil sands extraction, ... by the non-profit organization Near Zero. The results are ... and includes both supporters and opponents of the pipeline. ... could lead to significantly higher greenhouse gas emissions, with ... , "This report examines three main scenarios discussed ...
Breaking Biology News(10 mins):Global shift away from cars saves US$100 trillion, eliminates 1,700 MT of CO2 pollution 2Global shift away from cars saves US$100 trillion, eliminates 1,700 MT of CO2 pollution 3Global shift away from cars saves US$100 trillion, eliminates 1,700 MT of CO2 pollution 4Global shift away from cars saves US$100 trillion, eliminates 1,700 MT of CO2 pollution 5Microbiome research shows each tree species has a unique bacterial identity 2Keystone XL would likely raise oil sands production and greenhouse gas emissions 2
... at Johns Hopkins report using a laser beam to activate ... act like a school of fish turning in social unison, ... The study of this unexpected cell movement, reported ... importance for understanding embryonic development, wound healing and tumor metastasis ...
... In the year since their 2008 preliminary ranking, Cell Press journals ... saw their Impact Factors surge, according to new data released ... the report released June 17, Cell Stem Cell ,s rating ... previous score. Cell Host and Microbe ranks 13.021 - ...
... tropical diseases, left aside by big pharma and governments alike, ... more attention has to be paid to early diagnosis and ... Organization urgently need to be changed. So say scientists of ... years of research in Congo. The disease is caused ...
Cached Biology News:Fly cells flock together, follow the light 2Fly cells flock together, follow the light 3New 2009 Impact Factors soar for newest Cell Press journals 2WHO guidelines on Buruli ulcer need adjustment 2
Affinity Purified Rabbit Anti-mouse sRANKL Biotinylated Polyclonal Antibody...
Polyclonal antiserum raised against conjugated L-isoleucine. Available as antiserum. Amino Acid Antibodies...
... in heart tissues, and is produced ... conditions. Treatment of cells with ... TIMP-4 in some cell types, but ... require concentration of cell culture media ...
Mouse monoclonal [002-49] to C1s ( Abpromise for all tested applications). entrezGeneID: 716 SwissProtID: P09871...
Biology Products: